Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.

Peters L, McCarthy AE, Faught C.

Int J Infect Dis. 2009 Nov;13(6):e501-3. doi: 10.1016/j.ijid.2009.02.009. Epub 2009 Jun 4.

2.

Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).

Lambertucci JR, Leão FC, Barbosa AJ.

Rev Soc Bras Med Trop. 2003 Jul-Aug;36(4):541-2. Epub 2003 Aug 13. No abstract available.

3.

Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru.

Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO.

Am J Trop Med Hyg. 1999 Jan;60(1):146-9.

4.

Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.

Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J.

Am J Trop Med Hyg. 2006 Feb;74(2):246-9.

5.

[Recurrent strongyloidiasis as an indicator of HTLV-1 infection].

Richter J, Schwarz U, Duwe S, Ellerbrok H, Poggensee G, Pauli G.

Dtsch Med Wochenschr. 2005 Apr 22;130(16):1007-10. German.

PMID:
15830313
6.

Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.

Carvalho EM, Da Fonseca Porto A.

Parasite Immunol. 2004 Nov-Dec;26(11-12):487-97. Review.

7.

Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.

Pacanowski J, Santos MD, Roux A, LE Maignan C, Guillot J, Lavarde V, Cornet M.

Am J Trop Med Hyg. 2005 Jul;73(1):122-4.

8.

Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).

Agapé P, Copin MC, Cavrois M, Panelatti G, Plumelle Y, Ossondo-Landeau M, Quist D, Grossat N, Gosselin B, Fenaux P, Wattel E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):394-402.

PMID:
10096585
9.

Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.

Porto MA, Alcântara LM, Leal M, Castro N, Carvalho EM.

Am J Trop Med Hyg. 2005 Feb;72(2):124-5.

10.

Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.

Einsiedel L, Fernandes L.

Intern Med J. 2008 Sep;38(9):697-703. doi: 10.1111/j.1445-5994.2008.01775.x.

PMID:
19143887
11.

Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.

Arch EL, Schaefer JT, Dahiya A.

Dermatol Online J. 2008 Dec 15;14(12):6.

12.

Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.

Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E.

J Infect Chemother. 2003 Dec;9(4):355-7.

PMID:
14691660
13.

Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.

Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E.

Int J Infect Dis. 2002 Mar;6(1):28-30.

PMID:
12044298
14.

Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.

Dixon AC, Yanagihara ET, Kwock DW, Nakamura JM.

West J Med. 1989 Oct;151(4):410-3.

15.

Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil.

Chieffi PP, Chiattone CS, Feltrim EN, Alves RC, Paschoalotti MA.

Mem Inst Oswaldo Cruz. 2000 Sep-Oct;95(5):711-2.

16.

Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.

Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, Zabel P, Lange C.

Infection. 2005 Oct;33(5-6):383-6.

PMID:
16258873
17.

A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1.

Lagacé-Wiens PR, Harding GK.

CMAJ. 2007 Aug 28;177(5):451-3. No abstract available.

18.

Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.

Stewart DM, Ramanathan R, Mahanty S, Fedorko DP, Janik JE, Morris JC.

Acta Haematol. 2011;126(2):63-7. doi: 10.1159/000324799. Epub 2011 Apr 7.

19.

[Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].

Freites A.

Invest Clin. 2008 Dec;49(4):455-6. Spanish. Erratum in: Invest Clin. 2009 Mar;50(1):131.

PMID:
19245164
20.

Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.

Segarra-Newnham M.

Ann Pharmacother. 2007 Dec;41(12):1992-2001. Epub 2007 Oct 16. Review.

PMID:
17940124
Items per page

Supplemental Content

Write to the Help Desk